Calithera Biosciences, Inc. (NASDAQ: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE